Back
CEL-SCI Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
20
CVM
CEL-SCI
Last Price:
$0.29
Seasonality Move:
20.56%
Sell
43
NBY
NovaBay Pharmaceuticals
Last Price:
$0.64
Seasonality Move:
-8.46%
Sell
43
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.64. The Score for NBY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.64The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CVM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 36.51 | Sell |
Chaikin Money Flow: | -865864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.32 - 0.42) | Sell |
Bollinger Bands (100): | (0.37 - 0.77) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 51.45 | Buy |
Chaikin Money Flow: | 37786 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.61 - 0.67) | Sell |
Bollinger Bands (100): | (0.57 - 0.71) | Sell |
CVM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.33 | Sell |
20-day SMA: | 0.37 | Sell |
50-day SMA: | 0.41 | Sell |
200-day SMA: | 0.88 | Sell |
8-day EMA: | 0.33 | Sell |
20-day EMA: | 0.36 | Sell |
50-day EMA: | 0.43 | Sell |
200-day EMA: | 0.88 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.6 | Buy |
20-day SMA: | 0.63 | Buy |
50-day SMA: | 0.65 | Sell |
200-day SMA: | 1.12 | Sell |
8-day EMA: | 0.61 | Buy |
20-day EMA: | 0.62 | Buy |
50-day EMA: | 0.64 | Sell |
200-day EMA: | 3.08 | Sell |
CEL-SCI Earnings Growth & CVM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
CEL-SCI Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |